988TiP - ARIEL4: An international, randomised phase 3 study of the PARP inhibitor rucaparib vs chemotherapy for the treatment of BRCA-mutated, relapsed, high-grade ovarian cancer
| Autor: | Kristeleit, R.S., Lorusso, D., Oaknin, A., Safra, T., Swisher, E.M., Bondarenko, I.M., Huzarski, T., Klat, J., Moiseyenko, V., Póka, R.L., Viola, L.S., Tankersley, C., Maloney, L., Goble, S., Unger, C., Dowson, A., Giordano, H., Oza, A.M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v352-v352 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|